Lilly Continues Positive Outlook For Migraine Treatment

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says a 12-month Phase 3 study of a migraine treatment has shown continued positive results. The pharmaceutical giant says the study for galcanezumab showed a "statistically significant reduction in the number of monthly migraine headache days" among patients.

Lilly says the treatment "demonstrated a positive safety and tolerability profile in patients with migraine, consistent with previous studies." Patients received two different doses and the company says there was "no clinically meaningful difference" in the rate of adverse effects between the dosages. 

Lilly's previously-announced plans to submit a Biologics License Application to the U.S. Food and Drug Administration remain set for the second half of 2017. The company also plans to submit to other regulatory agencies throughout the world.

"These long-term results are significant for the millions of Americans with migraine. They reinforce the efficacy and safety profile of galcanezumab while supporting its potential use as a self-administered, monthly injection," said Christi Shaw, president of Lilly Bio-Medicines. "After more than two decades of research, Lilly is excited to submit galcanezumab to the FDA as a new potential treatment option that can provide more migraine-free days for people suffering with migraine."

Lilly is presenting the results of the study at the 18th Congress of the International Headache Society in Vancouver. The company also plans to submit the findings for publication in a peer-reviewed journal "in the coming year."

The announcement comes just one day after Lilly detailed plans for a global restructuring, affecting about 3,500 employees. The company said the move will allow it to invest in the next generation of new medicines.

  • Perspectives

    • The Terrorist to Fear Most May be an Employee's Spouse

      As the world sees more small-scale terrorist attacks, some employers worry about their places of business becoming targets. The odds are much larger that they'll face a different kind of terror: one from an employee's personal life. The reality is that what we normally think of as terrorism presents only a miniscule threat to most Americans. There is, however, one very real threat of violence to your business.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Holcomb Nominates Opportunity Zones

      Governor Eric Holcomb has submitted nominations to the U.S. Secretary of the Treasury for dozens of Hoosier communities to earn the newly-created Opportunity Zone designation. The federal program, which was created with the passage of the Tax Cuts and Jobs Act, provides tax incentives to attract private investment to low-income communities.

    • The Terrorist to Fear Most May be an Employee's Spouse

      As the world sees more small-scale terrorist attacks, some employers worry about their places of business becoming targets. The odds are much larger that they'll face a different kind of terror: one from an employee's personal life. The reality is that what we normally think of as terrorism presents only a miniscule threat to most Americans. There is, however, one very real threat of violence to your business.

    • (Rendering provided by the city of Fishers.)

      Flexware Innovation Details New Fishers HQ

      Fishers-based Flexware Innovation Inc. is planning to relocate within the city to a new headquarters in a more prominent location. The company, which also has an office in Valparaiso and a presence at the new Indiana IoT Lab in Fishers, says the $3.5 million project near the Nickel Plate District Amphitheater could break ground in the fall. The company is seeking more than $265,000 in tax incentives from the city. Late last year, it announced plans to invest some $8 million into...

    • Six Finalists Vying For 'Stellar' Designation

      Six regions have been selected as finalists for the 2018 Stellar Communities Program. The initiative, which is taking a regional approach this year for the first time, involves support from the state to help boost strategic planning efforts in participating communities. Stellar Communities is driven by the Indiana Office of Community and Rural Affairs and previously involved smaller cities and towns. OCRA Executive Director Jodi Golden says...

    • Levementum Scores Funding, Sells Off Product

      Arizona-based Levementum, which has a growing presence in Indianapolis, says it has raised an additional $4 million in funding, led by Inoca Capital Partners. Chief Executive Officer Doug Guilbeau also says the company has sold its SugarCRM practice to focus on its Salesforce products and becoming "the top digital consultancy focused on consumer engagement." Levementum says the funding from the private equity firm will help support...